Hepatic steatosis is associated with reduced GH and IGF-I levels [57,58,59] and there is an inverse relationship between IGF-I levels and concentrations of inflammatory biomarkers [59,60,61] and fibrosis score [61] in these subjects. This evidence concerns the gene IGF1 and fatty liver disease.